Regent Peak Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Regent Peak Wealth Advisors's AMGN Position: Q2 2026 in Review
Regent Peak Wealth Advisors increased its Amgen (AMGN) stake by 2.2% in Q2 2026, buying an estimated $12.7K and bringing the position to 1,729 shares worth $626K. The position accounts for 0.12% of the portfolio, ranked #82.
Regent Peak Wealth Advisors first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.82M in Q2 2024. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Regent Peak Wealth Advisors held 1,729 shares of Amgen worth $626K as of Q2 2026.
- Regent Peak Wealth Advisors bought 37 Amgen shares in Q2 2026, an estimated $12.7K.
- Amgen made up 0.12% of Regent Peak Wealth Advisors's portfolio in Q2 2026, its #82 holding.
- Regent Peak Wealth Advisors first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
- Regent Peak Wealth Advisors's Amgen position peaked at $2.82M in Q2 2024.
- 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Regent Peak Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.